Real-time continuous glucose monitoring (CGM) can reduce the number of hypoglycaemic events in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia, according to a German study. The findings published in The Lancet support calls for adults with type 1 diabetes to have better access to CGM – currently only subsidised in Australia ...
Type 1 diabetes
Evidence on hypoglycaemic events backs expansion of CGM subsidy to adults
By Mardi Chapman
23 Feb 2018